New Study Reveals NatureKnit, a Patented, Natural Microbiome Ingredient, Exhibits a More Gentle and Significant Prebiotic Effect Compared with Purified Fibers
MOMENCE, Ill., March 20, 2025 /PRNewswire/ -- New research published in Microorganisms has…
AirHelp Secures Significant Minority Investment from Abry Partners
BERLIN, March 18, 2025 /PRNewswire/ -- AirHelp Inc. ("AirHelp"), the global leader in…
ExoPTEN Preclinical Study Demonstrates Significant Potential for Enhancing Motor Function, Blood Flow, and Spinal Cord Injury Recovery
TORONTO and HAIFA, Israel, March 14, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic…
Golden Gate Global Celebrates Significant Improvement in I-829 Petition Processing Timelines
SAN FRANCISCO, Feb. 20, 2025 /PRNewswire/ -- Golden Gate Global (GGG), a…
Apptronik Raises $350 Million to Scale Production of AI-Powered Humanoid Robots and Meet Significant Customer Demand
B Capital, Capital Factory and Google back Apptronik in the race to…
Myriad Genetics RiskScore Study Named One of the Top 10 Significant Advances in Genomic Medicine in American Journal of Human Genetics
SALT LAKE CITY, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc.…
GNT Pharma Reports Significant Improvements in Stroke Patients Treated with its pioneering Phase 3 Drug Nelonemdaz
** IND submitted to the FDA showing significantly improved patient condition when…
GNT Pharma Reports Significant Improvements in Stroke Patients Treated with its pioneering Phase 3 Drug Nelonemdaz
** IND submitted to the FDA showing significantly improved patient condition when…
Open-Label Extension Data Confirms Sustained Benefit of Acoramidis on Cardiovascular Outcomes, Including Statistically Significant Reduction in ACM Within 36 Months
November 18, 2024 11:15 ET | Source: BridgeBio Pharma, Inc. - Acoramidis…
Trump Wins the U.S. Election: Cryptocurrency Staking Market Primed for Significant Growth with STAKING AI at the Helm
Los Angeles, CA, Nov. 08, 2024 (GLOBE NEWSWIRE) -- With the announcement…